Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury
Status:
Terminated
Trial end date:
2018-11-06
Target enrollment:
Participant gender:
Summary
This study evaluates the use of nebulized hypertonic saline (aerosolized salt water) as a
preventive treatment for post-traumatic acute lung injury (ALI). Both animal and human
research indicate that aerosolized salt water might help reduce harmful inflammation with
minimal risks.
Phase:
Phase 1
Details
Lead Sponsor:
Denver Health and Hospital Authority
Collaborators:
National Institutes of Health (NIH) University of Colorado, Denver